BCKDHB gene
The BCKDHB gene is essential for producing the beta subunit of the BCKD enzyme complex, which is required to process specific amino acids for cellular energy.
Normal Function
The BCKDHB gene provides instructions for making the beta subunit of the branched-chain alpha-keto acid dehydrogenase (BCKD) enzyme complex. Two beta subunits pair with two alpha subunits (produced from the BCKDHA gene) to form the E1 component of the enzyme complex.
The BCKD enzyme complex functions within mitochondria to break down three dietary amino acids: leucine, isoleucine, and valine. This process is vital for converting these protein building blocks into molecules that the body uses for energy.
Health Conditions Related to Genetic Changes
Maple syrup urine disease
Over 90 mutations in the BCKDHB gene have been linked to maple syrup urine disease. These mutations often result in the severe, classic form of the disorder.
- Symptoms: Affected infants may exhibit poor feeding, vomiting, lethargy, abnormal movements, delayed development, and urine that has a characteristic sweet odor.
- Mechanism: Mutations in the BCKDHB gene prevent the BCKD enzyme complex from breaking down leucine, isoleucine, and valine. The buildup of these amino acids and their byproducts is toxic to the nervous system, causing seizures and developmental issues.
- Specific Mutations: Mutations may involve single amino acid changes or small insertions/deletions of DNA. A common mutation in the Ashkenazi Jewish population replaces arginine with proline at position 183 (Arg183Pro or R183P).
Other Names for This Gene
- 2-oxoisovalerate dehydrogenase beta subunit
- BCKDH E1-beta
- branched chain keto acid dehydrogenase E1, beta polypeptide
- branched chain keto acid dehydrogenase E1, beta polypeptide (maple syrup urine disease)
- ODBB_HUMAN